1. Clinical Overview
Cerebroprotein Hydrolysate is a sterile, pyrogen-free, low molecular weight preparation derived from porcine brain tissue through enzymatic hydrolysis. It contains biologically active peptides, free amino acids, and nucleotides. In the Indian market, it is primarily used as a neurotrophic and neuroprotective agent, believed to support neuronal survival, enhance synaptic plasticity, and promote functional recovery in various neurological conditions. It is administered via intramuscular injection or intravenous infusion.
| Onset | Duration | Bioavailability |
|---|---|---|
| The onset of action is not precisely defined due to its neuromodulatory and trophic nature. Clinical effects on cognitive and functional parameters are typically observed after several weeks of therapy (2-4 weeks). | The duration of action is prolonged and may persist for several weeks after discontinuation of therapy, correlating with its proposed effects on neuronal repair and plasticity. | Approximately 50-70% following intramuscular administration. Intravenous administration provides 100% bioavailability. |
2. Mechanism of Action
The exact mechanism is multifactorial and not fully elucidated. It is proposed to mimic the action of endogenous neurotrophic factors. The preparation contains a complex mixture of low molecular weight peptides (< 10 kDa) and amino acids that can cross the blood-brain barrier. It is believed to promote neuronal survival, stimulate neurite outgrowth, enhance synaptogenesis, and improve cerebral glucose utilization. It may also modulate neurotransmitter systems and possess antioxidant properties.
3. Indications & Uses
- Vascular Dementia
- Post-stroke Cognitive Impairment and Functional Recovery
- Traumatic Brain Injury (for cognitive sequelae)
- Cognitive impairment associated with cerebrovascular disease
4. Dosage & Administration
Adult Dosage: 30mg to 60mg once daily, administered intramuscularly or by slow intravenous infusion in 100-250 mL of normal saline. The 60mg dose is common for moderate to severe conditions. A typical treatment course is 10-30 days, which may be repeated after an interval.
Administration: For IM use: Administer by deep intramuscular injection. For IV use: Dilute the required dose in 100-250 mL of 0.9% Sodium Chloride Injection. Administer as a slow intravenous infusion over 60-90 minutes. Do not mix with other medications in the same infusion. A skin test is recommended before starting treatment: inject 0.1 mL of a 1:10 dilution intradermally; a wheal > 1.5 cm indicates positive reaction.
5. Side Effects
Common side effects may include:
- Injection site pain, redness, or induration (IM route)
- Mild fever (pyrogenic reaction)
- Headache
- Dizziness
- Fatigue
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Anticoagulants (Warfarin, NOACs) | Theoretical risk of increased bleeding due to potential platelet inhibition; monitor coagulation parameters. | Moderate |
| Antiepileptic Drugs | Potential for lowered seizure threshold; may require adjustment of AED dose. | Moderate |
| Other Nootropic/Cerebral Activators (Piracetam, Citicoline) | Additive pharmacological effects; clinical significance unknown. | Mild |
| Antihypertensives | Potential additive hypotensive effect, especially with IV infusion; monitor BP. | Moderate |
7. Patient Counselling
- Do inform your doctor about any history of allergies, especially to pork products or other drugs.
- Do report any rash, itching, or breathing difficulty immediately.
- Do attend all scheduled injections for the full course as prescribed.
- Don't skip the pre-treatment skin test if advised by your doctor.
- Don't self-administer; this is an injectable product for professional use only.
8. Toxicology & Storage
Overdose: No specific reports of acute overdose in humans. Symptoms may be an exaggeration of known side effects: severe hypotension, fever, chills, headache, and possible allergic reactions.
Storage: Store below 25°C. Protect from light. Do not freeze. Keep the vial in the outer carton. The solution should be clear and colorless to slightly yellow; do not use if discolored or if particulate matter is present. After dilution for IV infusion, use immediately. Do not store diluted solutions.